Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Shook
Brian C
BC
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, PO Box 776, Spring House, PA 19477, United States. bshook@its.jnj.com
Rassnick
Stefanie
S
Chakravarty
Devraj
D
Wallace
Nathaniel
N
Ault
Mark
M
Crooke
Jeffrey
J
Barbay
J Kent
JK
Wang
Aihua
A
Leonard
Kristi
K
Powell
Mark T
MT
Alford
Vernon
V
Hall
Daniel
D
Rupert
Kenneth C
KC
Heintzelman
Geoffrey R
GR
Hansen
Kristen
K
Bullington
James L
JL
Scannevin
Robert H
RH
Carroll
Karen
K
Lampron
Lisa
L
Westover
Lori
L
Russell
Ronald
R
Branum
Shawn
S
Wells
Kenneth
K
Damon
Sandra
S
Youells
Scott
S
Beauchamp
Derek
D
Li
Xun
X
Rhodes
Kenneth
K
Jackson
Paul F
PF